Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
New cases of mesothelioma, 2015, UK
Deaths from mesothelioma, 2016, UK
Preventable cases of mesothelioma, UK
- There are around 2,700 new mesothelioma cases in the UK every year, that's more than 7 every day (2013-2015).
- Mesothelioma is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2015).
- In males in the UK, mesothelioma is the 18th most common cancer, with around 2,300 new cases in 2015.
- In females in the UK, mesothelioma is not among the 20 most common cancers, with around 450 new cases in 2015.
- Incidence rates for mesothelioma in the UK are highest in people aged 80 to 84 (2013-2015).
- Since the early 1990s, mesothelioma incidence rates have increased by around two-thirds (67%) in the UK. Rates in males have increased by almost three-fifths (58%), and rates in females have increased by almost two times (96%).
- Over the last decade, mesothelioma incidence rates have increased by more than a twentieth (7%) in the UK. Rates in males have remained stable, and rates in females have increased by almost a sixth (16%).
- Most mesotheliomas occur in the pleura.
- Incidence rates for mesothelioma are projected to fall by 53% in the UK between 2014 and 2035, to 3 cases per 100,000 people by 2035.
- Mesothelioma in England is not associated with deprivation.
- An estimated 2,900 people who had previously been diagnosed with mesothelioma were alive in the UK at the end of 2010.
- Worldwide, around 14,200 new cases of mesothelioma are diagnosed each year, with incidence rates varying across the world.
- There are around 2,500 mesothelioma deaths in the UK every year, that's around 7 every day (2014-2016).
- Mesothelioma is the 18th most common cause of cancer death in the UK, accounting for 2% of all cancer deaths (2016).
- In males in the UK, mesothelioma is the 15th most common cause of cancer death, with around 2,100 deaths in 2016.
- In females in the UK, mesothelioma is not among the 20 most common causes of cancer death, with around 400 deaths in 2016.
- More than half (52%) of mesothelioma deaths in the UK each year are in people aged 75 and over (2012-2014).
- Mortality rates for mesothelioma in the UK are highest in people aged 80-89 (2012-2014).
- Since the early 1970’s mesothelioma mortality rates have increased by more than nine-fold in Great Britain. The increase is larger in males (902%), than in females (692%).
- Over the last decade, mesothelioma mortality rates have increased by more than a tenth (14%) in the UK, with a smaller increase in males (10%) than in females (29%).
- The number of mesothelioma deaths in Great Britain is expected to peak in 2017-2018 and decline rapidly thereafter. This is due to the changing patterns of exposure to asbestos, the main cause of mesothelioma.
- Mortality rates for mesothelioma are projected to fall by 46% in the UK between 2014 and 2035, to 3 deaths per 100,000 people by 2035.
- Mesothelioma in England is not associated with deprivation.
- Mesothelioma survival in England is highest for people diagnosed aged under 50 years old (2009-2013).
- Almost 3 in 20 men and almost a third of women in England diagnosed with mesothelioma aged 15-49 survive their disease for five years or more, compared with around 5 in 100 people diagnosed aged 80 and over (2009-2013).
- Five-year relative survival for mesothelioma in men is below the European average in England and Scotland but similar to the European average in Wales.
- Five-year relative survival for mesothelioma in women is below the European average in England.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 1 in 212 UK males and 1 in 963 UK females will be diagnosed with mesothelioma in their lifetime.
- 94% of mesothelioma cases in the UK are preventable.
- 94% of mesothelioma cases in the UK are caused by workplace exposures.
- 'Emergency presentation' is the most common route to diagnosing mesothelioma.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for lung cancer.
The latest statistics available for mesothelioma are; incidence 2015, mortality 2015 and survival 2009-2013 (by age).
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Mortality trends data are taken from the mesothelioma register, a database maintained by the Health and Safety Executive, comprising all deaths in Great Britain that mention 'mesothelioma' anywhere on the death certificate. This is the most reliable source of information on mesothelioma mortality, because it is compiled by tracking incident mesothelioma cases and additionally checking national death data. Prior to the ICD-10 coding system, which assigns mesothelioma a specific code, mesothelioma deaths were coded according to their anatomical site and therefore often confused with lung and other cancers.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Mesothelioma is part of the group 'Lung cancer' for cancer waiting times data. Codes vary per country but broadly include: trachea, bronchus and lung, thymus, heart, mediastinum and pleura, other and ill-defined sites of the respiratory system, mesothelioma, secondary cancers of the mediastinum, pleura or other and unspecified respiratory organs.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.